India Blood Bags Market

The India Blood Bags Market Size is projected USD 56.13 Million in 2025 and is forecasted to reach around USD 99.89 Million by 2035. According to Decision Advisors, a detailed report on analysis of the India Blood Bags Market indicates that the increasing adoption of blood component separation. trend dominates the market, accounting for approx. 55–60% of the total India demand worldwide. Terumo Penpol Pvt. Ltd. is one of the most dominating companies in India’s Blood Bags Market, supported by revenue of approx. USD 19–20 million, due to strong manufacturing capacity, government contracts, wide distribution network, and advanced blood bag technology portfolio.

Market Snapshot

• India Blood Bags Market Size (2025): USD 56.13 Million
• India Blood Bags Market Projected Market Size (2035): USD 99.89 Million
• India Blood Bags Market Compound Annual Growth Rate (CAGR): 5.93%
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

Market Overview/Introduction

India Blood Bags Market represents the manufacture, supply, and consumption of sterile single-use bags for collecting, storing, transferring, and transfusing blood as well as its derivatives. Blood bags represent medical grade plastic bags with anticoagulants and chambers for separating the components of blood including plasma, platelets, and red blood cells. The use of blood bags is extensive in hospitals, blood banks, and diagnostics centres in various applications such as surgery, trauma, cancer treatment, and other diseases. These are essential tools for the prevention of infections, preservation of blood quality, and performing transfusions. The growth in demand for blood bags in India is propelled by the rise in the need for transfusions of blood owing to the increased instances of surgeries, accident victims, anaemia cases, and chronic diseases among others. Moreover, the development in health infrastructure and increase in awareness regarding voluntary blood donations is positively impacting the demand for blood bags. The technological innovations involve the creation of DEHP-free products, use of biodegradable materials, and incorporation of safety measures to prevent any contamination threats. The automation process for the collection and processing of blood has proven to be more efficient as well. The government policies have a major role in the expansion of the market. Initiatives from the National Blood Transfusion Council and Ministry of Health & Family Welfare contribute significantly towards voluntary blood donation campaigns, effective blood bank systems, and maintaining the standards of quality.

• In January 2026: The National Blood Transfusion Bill was tabled in Parliament, proposing a central authority to standardize blood collection, testing, and storage, strengthening India’s transfusion safety framework.

• In April 2024: India strengthened External Quality Assurance Scheme (EQAS) guidelines for transfusion-transmitted infections, improving testing accuracy and quality control across blood banks, enhancing safety and standardization in blood management systems.

Notable Insights: -

• By Product Type, the Single Blood Bag segment holds a dominant position with an estimated share of over 43% in 2025.
• By Application, the Collection Blood Bags Blood Bags segment holds a dominant position with an estimated share of over 67% in 2025.
• By End User, the Clinics segment holds a dominant position with an estimated share of over 48% in 2025.
• By Capacity, the Chronic constipation segment holds a dominant position with an estimated share of over 38% in 2025.
• The forecasted CAGR for the India Blood Bags market is expected to be about 5.93% for the period between 2026 and 2035.
• The market is expected to reach a valuation of approximately USD 99.89 Million by 2035

What is the Role of Technology in Grooming the Market?

Technological advances have been essential in influencing the dynamics of the India Blood Bags Market through ensuring blood collection, transportation, and storage are safe, efficient, and reliable. Today, blood bags used for collecting blood have been made to allow component separation to ensure that donated blood is utilized effectively. Technology has enabled the development of new blood bags with DEHP-free and biocompatible materials to minimize risks associated with blood transfusions, whereas advancements in anticoagulant solutions have increased the shelf life of stored blood. Besides, automation of blood collection and processing ensures reliability, consistency, and minimal risks of contaminations.

Market Drivers

Some of the major factors driving the India Blood Bags Market are explained below. The first factor that has increased the demand for blood bags is the rise in the prevalence of surgeries, traumatic injuries, and other illnesses such as anaemia, cancer, and renal conditions that necessitate blood transfusion frequently. Moreover, the rise in the number of road accidents and the need for emergency services has boosted the demand for secure blood storage. The rising number of people participating voluntarily in blood donation campaigns organized by the National Blood Transfusion Council and the Ministry of Health and Family Welfare is another important factor propelling the India Blood Bags Market. The growing popularity of component transfusion therapy will help boost the uptake of blood bags that can hold more than one component. In addition to this, upgraded healthcare facilities in tier-2 and tier-3 cities have played a pivotal role in boosting market growth.

Restraints

The India Blood Bags Market faces restraints such as stringent regulatory requirements and quality standards, increasing compliance costs for manufacturers. Limited awareness and infrastructure in rural areas restrict optimal blood collection and storage. Additionally, risks of contamination and improper handling, along with dependence on PVC-based materials, pose safety and environmental concerns, slightly hindering market growth.

Study on the Supply, Demand, Distribution, and Market Environment

India’s blood bags market is characterized by a balance and an ever-changing equilibrium in terms of demand and supply dynamics.

• Demand Increased surgical procedures, trauma cases, and higher blood donation campaigns have resulted in high consumption rates from hospitals and blood banks.
• Supply: Indian suppliers including Terumo Penpol Pvt. Ltd. and many others have been supplying this product steadily.
• The process of distribution relies on public sector purchases and hospitals together with medical distributors to cover all parts of the country, although penetration into rural areas is still quite low. The market environment in India has been largely influenced by the regulations set up by the Central Drugs Standard Control Organization.

Price Analysis and Consumer Behaviour Analysis

The price analysis in the India Blood Bags Market highlights cost consciousness within both the public and private sectors of health care. The India Blood Bags Market size was estimated to be around USD 18.3 million in 2024, showing a steady growth rate. The prices are competitive due to procurement from the government and bulk buying; however, factors such as the cost of raw material, regulations, and quality testing determine cost structures.  In terms of consumer behaviour analysis, consumers of blood bags include hospitals and blood banks, and not end users like individuals. The annual demand for blood in India is estimated to be 14.6 million units, where the shortfall is almost 1 million units per year, resulting in high dependence on storing blood efficiently. Quality, safety, and regulations are more important than cost in purchase behaviour.

Market Segmentation

The India Blood Bags Market is categorised by product type, application, capacity and end user

• The Single Blood Bag segment dominated the market in 2025 and is projected to grow at a steady CAGR of approximately 8.7% during the forecast period.

Based on the product type, the India Blood Bags Market is divided into Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, And Penta Blood Bag. Among these, Single Blood Bags dominate the India Blood Bags market, accounting for approximately 40–45% of total revenue in 2025. Their leadership is driven by widespread use in whole blood collection, low cost, and suitability for basic healthcare settings and blood donation camps. However, Triple Blood Bags are the fastest-growing segment, projected to register a CAGR of around 8–9%, due to increasing demand for component separation (RBCs, plasma, platelets) in advanced hospitals and blood banks across India.

• The Collection Blood Bags Blood Bags segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR of approximately 6.5% during the forecast period.

Based on the Application, the India Blood Bags Market is divided into Collection Blood Bags, and Transfer Blood Bags. Among these, Collection Blood Bags dominate the blood bags market, accounting for approximately 65–70% of total revenue in 2025. Their dominance is driven by extensive use in blood donation drives, hospitals, and blood banks for primary collection and storage. These bags are essential in both routine and emergency transfusion settings. Meanwhile, Transfer Blood Bags hold a smaller share but are expected to grow steadily, registering a CAGR of around 6–7%, supported by increasing adoption of blood component separation practices.

• The 450 ml blood bags segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR of approximately 6.5% during the forecast period.

Based on the Capacity, the India Blood Bags Market is divided into 100 ml, 150 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml, 500 ml. Among these, 450 ml blood bags dominate the market, accounting for approximately 35–40% of total revenue in 2025. Their dominance is due to standardization in blood collection practices, allowing optimal volume for component separation into red cells, plasma, and platelets. These bags are widely used across hospitals and blood banks for routine donations. Additionally, this segment is expected to grow steadily, registering a CAGR of around 6–7%, driven by rising blood donation rates and increasing demand for transfusion therapies.

• The Blood Banks segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR of approximately 7.6% during the forecast period.

Based on the End User, the India Blood Bags Market is divided into Hospital, Clinics, Blood Banks Ambulatory Surgical Centres (ASCs), and Others. Among these, the Blood Banks dominate the India Blood Bags market, accounting for approximately 45–50% of total revenue in 2025. Their leading share is driven by their central role in blood collection, testing, storage, and distribution across healthcare systems. Government-supported donation programs and rising voluntary blood donations further strengthen demand in this segment. Meanwhile, Hospitals are the fastest-growing end user, expected to register a CAGR of around 7–8%, supported by increasing surgeries, trauma cases, and in-house transfusion services.

Recent Developments

• In April 2024, MacoPharma SA introduced advanced blood bag systems with enhanced sterility assurance and improved storage performance, supporting safer transfusion practices and technology adoption in India.

• In November 2023, Blod.in launched Blod+, India’s first on-demand blood logistics platform, improving delivery speed, reducing wastage, and strengthening blood supply chain efficiency.

• In May 2023, Fresenius Kabi AG strengthened its Asia-Pacific operations, targeting growth in China and emerging markets, supporting blood collection and transfusion product demand, including India’s expanding healthcare sector.

• In June 2025, Kerala launched a Blood Bank Traceability Project across government hospitals, enabling digital tracking of blood from collection to transfusion, improving transparency and strengthening India’s blood management system.

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the India Blood Bags market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in the India Blood Bags Market

• Terumo Penpol Pvt. Ltd.
• Poly Medicure Ltd.
• HLL Lifecare Limited
• Fresenius Kabi AG
• Grifols S.A.
• MacoPharma SA
• Haemonetics Corporation
• B. Braun Melsungen AG
• SURU International Pvt. Ltd.
• Span Healthcare Pvt. Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segmentation

This study forecasts revenue at the national and regional levels from 2021 to 2035. The report segmented the India Blood Bags Market based on the following segments:

India Blood Bags Market, By Product Type

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag

India Blood Bags Market, By Application

• Collection Blood Bags
• Transfer Blood Bags

India Blood Bags Market, By Capacity

• 100 ml
• 150 ml
• 250 ml
• 300 ml
• 350 ml
• 400 ml
• 450 ml
• 500 ml

India Blood Bags Market, By End User

• Hospital
• Clinics
• Ambulatory Surgical Centres (ASCs)
• Others

Frequently Asked Questions (FAQ)

1. What regulatory approvals are required for manufacturing blood bags in India?

Blood bags in India must comply with medical device regulations governed by the Central Drugs Standard Control Organization. Manufacturers are required to obtain appropriate licenses, adhere to quality standards, and follow Good Manufacturing Practices (GMP) to ensure product safety and efficacy.

2. How does import dependency affect the India Blood Bags Market?

Although India has a strong domestic manufacturing base, certain advanced technologies and raw materials are still imported. This dependency can influence pricing, supply stability, and technology adoption within the market.

3. What role do private hospitals play in the market expansion?

Private hospitals contribute significantly by investing in advanced transfusion infrastructure, adopting modern blood storage technologies, and increasing demand for high-quality blood bags, thereby supporting overall market growth.

4. How does seasonal variation impact blood bag demand?

Demand for blood bags can fluctuate seasonally, with higher requirements during periods of increased accidents, surgeries, or disease outbreaks, while donation rates may vary during holidays or extreme weather conditions.

5. What are the key quality standards followed in blood bag production?

Blood bag manufacturing follows strict international standards such as ISO certifications and sterility guidelines, ensuring durability, biocompatibility, and safe storage of blood without contamination risks.